These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1268854)

  • 41. [Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
    Osieka R; Glatte P; Haedecke U; Schmidt CG
    Strahlentherapie; 1982 Oct; 158(10):620-9. PubMed ID: 7179344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
    Lown JW; Chauhan SM
    J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
    Selby PJ; Steel GG
    Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model.
    Castronovo FP; Potsaid MS; Kopiwoda S
    Cancer Res; 1980 Oct; 40(10):3473-4. PubMed ID: 7438035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates.
    Baril BB; Baril EF; Laszlo J; Wheeler GP
    Cancer Res; 1975 Jan; 35(1):1-5. PubMed ID: 162855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased cytotoxic sensitivity of YPC-1 tumor cells from mice treated with nitrosoureas.
    Hunyadi J; Szegedi G; Szabo T; Ahmed A; Laki K
    Cancer Res; 1981 May; 41(5):1677-81. PubMed ID: 6111391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneous in vitro sensitivities of metastatic B16 melanoma sublines and clones to retinoic acid or BCNU.
    Nicolson GL; Lotan R; Rios A
    Cancer Treat Rep; 1981; 65 Suppl 2():71-4. PubMed ID: 7346150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
    Hunter KJ; Deen DF; Pellarin M; Marton LJ
    Cancer Res; 1990 May; 50(9):2769-72. PubMed ID: 2109657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy of an experimental glioma with nitrosoureas.
    Tator CH; Day A; Ng R; Liberman L
    Cancer Res; 1977 Feb; 37(2):476-81. PubMed ID: 832271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanisms of cellular resistance to chloroethylnitrosourea in cell lines derived from human brain tumors].
    Aida T
    Hokkaido Igaku Zasshi; 1988 May; 63(3):348-61. PubMed ID: 3164699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Kohlhepp SJ; May HE; Reed DJ
    Drug Metab Dispos; 1981; 9(2):135-41. PubMed ID: 6113112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytogenetic effects of Me-CCNU on sister chromatid exchange frequency, cellular kinetics and chromosome aberrations.
    Shah VC; Vyas RC; Adhvaryu SG
    Neoplasma; 1986; 33(1):33-7. PubMed ID: 3754313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of B16 melanoma cells resistant to the CC-1065 analogue U-71,184.
    Moy BC; Petzold GL; Badiner GJ; Kelly RC; Aristoff PA; Adams EG; Li LH; Bhuyan BK
    Cancer Res; 1990 Apr; 50(8):2485-92. PubMed ID: 2317831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of tumorigenicity of B16 melanoma in heterogenetic mice by administration of copper chelates.
    Pierson HF
    Cancer Treat Rep; 1985 Nov; 69(11):1283-91. PubMed ID: 4092191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
    Hart IR; Fidler IJ
    Cancer Res; 1980 Jul; 40(7):2281-7. PubMed ID: 7388794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo drug sensitivity assay of clonogenic human melanoma cells and correlation with treatment outcome.
    Kirkwood JM; Marsh JC
    Cancer Res; 1983 Jul; 43(7):3434-40. PubMed ID: 6850650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Barker M; Hoshino T; Gurcay O; Wilson CB; Nielsen SL; Downie R; Eliason J
    Cancer Res; 1973 May; 33(5):976-86. PubMed ID: 4703128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.